GSK to Acquire RAPT Therapeutics for $2.2 Billion, Strengthening Its Immunology Pipeline
Deal delivers global rights to experimental food allergy therapy ozureprubart as GSK pursues growth under new CEO Luke Miels. Britain’s ...
Deal delivers global rights to experimental food allergy therapy ozureprubart as GSK pursues growth under new CEO Luke Miels. Britain’s ...
Teaming agreement positions Attune’s pipeline for immediate Strategic National Stockpile readiness while unlocking up to $75 million in shared revenue. ...
MOU with China-based GSO supports sustainable, asset-light expansion in Singapore’s residential market. Springview Holdings Ltd (SPHL) has taken a measured ...
Record rally underscores ASML’s central role in the global semiconductor and artificial intelligence boom. ASML Holding NV (ASML) has crossed ...
Binding LOI signals major expansion into regulated event-based trading, sending shares to new highs. Shares of High Roller Technologies, Inc. ...
Bitcoin’s renewed upside drives gains in crypto equities, though broader volatility still looms. Bitcoin (BTC) climbed notably today, trading near ...
Five-year agreement with Caban Energy strengthens domestic manufacturing and positions KULR at the center of mission-critical power infrastructure. KULR Technology ...
Transformative deal targets the biological roots of autism, opening a new frontier in disease-modifying therapy. XTL Biopharmaceuticals has taken a ...
Surging Gemini adoption and custom chip deals propel Alphabet into rarefied territory—just behind Nvidia. Google has officially entered one of ...
Legal action, boardroom battles, and a rival Netflix bid push Hollywood’s biggest takeover fight to a breaking point. The battle ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?